Discover B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 7 in our database
Found 61 in our records
HQ: New York, New York, United States
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
HQ: Cambridge, Massachusetts, United States
Cullinan Oncology
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@cullinanoncology.com (100.0%)
-
Corinne Savill
Chief Business Officer
c*****l@cullinanoncology.com
-
Nadim Ahmed
President and CEO
n****d@cullinanoncology.com
-
Jennifer Michaelson
Chief Development Officer
j*********n@cullinanoncology.com
-
Leslie Mariani
Vice President, Finance and Operations
l******i@cullinanoncology.com
-
Jeffrey Trigilio
Chief Financial Officer
j*******o@cullinanoncology.com
-
Sal Firicano
VP and Head of Information Technology
s*******o@cullinanoncology.com
-
General Inquiries
info@cullinoncology.com
HQ: Woodcliff Lake, New Jersey, United States
Eagle Pharmaceuticals
Eagle Pharmaceuticals is a company focused on deveShow more...loping and commercializing injectable products in the critical care and oncology areas.
HQ: Woodcliff Lake, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Pharmaceuticals
Business Type: Public
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: May 22, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: NASDAQ:EGRX
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@eagleus.com (100.0%)
-
Jorma Lalla
Vice President
j****a@eagleus.com
-
Brendan Killeen
Regional Sales Director
b******n@eagleus.com
-
David S Bricker
Vice President, Head Global Manufacturing and Supply
d******r@eagleus.com
-
Alan Eagle
a****e@eagleus.com
-
Daniel Maher
d****r@eagleus.com
-
General Inquiries
info@eagleus.com
-
Unclassified inbox
aelgohail@eagleus.com
-
Unclassified inbox
jlarocca@eagleus.com
-
Unclassified inbox
egrx@openboard.info
HQ: Seattle, Washington, United States
CTI BioPharma
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@ctibiopharma.com (100.0%)
-
Chuck Bianco
c*****o@ctibiopharma.com
-
Natalie Jaynes Brunner
Key Account Manager
n******r@ctibiopharma.com
-
patrizia angiuli
p******i@ctibiopharma.com
-
General Inquiries
medinfo@ctibiopharma.com
HQ: Seattle, Washington, United States
Fred Hutchinson
Fred Hutchinson Cancer Research Center provides seShow more...rvices for the prevention, early detection, and treatment of cancer and other diseases.
HQ: Seattle, Washington, United States
Specialized In: Biotechnology, Coaching & Consulting, Healthcare & Medical, Health Diagnostics, Travel & Hospitality, Hospitals & Clinics, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Aug 9, 2023
Founded Date: 1975
Company Type: For Profit
Operating Status: Active
4 Emails
1 Phones
-
k*****e@fredhutch.org
-
s****m@fredhutch.org
***********
-
a*************n@fredhutch.org
-
Unclassified inbox
communications@fredhutch.org
HQ: San Diego, California, United States
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutShow more...ions to advance patient care in oncology.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Pharmaceuticals
Business Type: Private
Employees: 11-50
Rounds: Venture - Series Unknown
Last Investment Activity: Oct 18, 2022
Founded Date: 2005
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Scott T. Megaffin
CEO
-
Unclassified inbox
cmiller@tragarapharma.com
HQ: Houston, Texas, United States
ImmunoMet Therapeutics
ImmunoMet Therapeutics is a biopharmaceutical compShow more...any that develops and commercializes oncology products for cancer patients.
HQ: Houston, Texas, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Series B
Last Investment Activity: Jul 26, 2021
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Edward Garmey
Consultant CMO
-
Sungwuk Kim
CEO
-
Revati Shreeniwas
Chief Medical Officer
-
General Inquiries
info@immunomet.com
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.